950130 — Access Bio Share Price
Last Trade - 00:00- KR₩915bn
- KR₩891bn
- KR₩297m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 27.99 | 26.06 | 36.57 | 36.94 | 103.21 | n/a | n/a | 26.83% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -69.97 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Access Bio, Inc. is engaged in research, development and manufacturing of in vitro rapid diagnostic tests, biosensor and molecular diagnostic products. The Company's vitro diagnostic technology includes immunochemical, biochemical and molecular products. Its product list includes rapid diagnostic tests, molecular diagnostics and biosensors. Its rapid diagnostic tests include CareStart G6PD RDT, which is a visual screening test that identifies glucose-6-phosphate dehydrogenase (G6PD) deficient patients using blood sample; CareStart Malaria, which are diagnostic tests that diagnose malaria infection from whole blood sample; CareStart Dengue Combo (NS1+IgM/IgG), which is a diagnostic test that can simultaneously detect dengue virus in all clinical stages using both dengue nonstructural 1 (NS1) antigen and anti-dengue antibodies (IgM/IgG), and CareStart Scrub Typhus IgM, which is a test intended for detection of immunoglobulin M (IgM) to O.tsutsugamushi in serum, plasma or whole blood.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- January 1st, 1970
- Public Since
- May 30th, 2013
- No. of Shareholders
- 75,623
- No. of Employees
- 63
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 35,602,012
- Address
- 65 CLYDE ROAD, SUITE A, SOMERSET, 08873
- Web
- http://www.accessbio.net
- Phone
- +1 7328734040
- Auditors
- Woori Accountants
Similar to 950130
BIODYNE ORD
Korea Exchange - KOSDAQ
FUTURECHEM ORD
Korea Exchange - KOSDAQ
GENCURIX ORD
Korea Exchange - KOSDAQ
GENESYSTEM ORD
Korea Exchange - KOSDAQ
GREEN GROSS ORD
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:54 UTC, shares in Access Bio are trading at KR₩25,700. This share price information is delayed by 15 minutes.
Shares in Access Bio last closed at KR₩25,700 and the price had moved by -13.05% over the past 365 days. In terms of relative price strength the Access Bio share price has underperformed the FTSE Developed Asia Pacific Index by -31.48% over the past year.
There is no consensus recommendation for this security.
Access Bio does not currently pay a dividend.
Access Bio does not currently pay a dividend.
Access Bio does not currently pay a dividend.
To buy shares in Access Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩25,700, shares in Access Bio had a market capitalisation of KR₩915bn.
Here are the trading details for Access Bio:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 950130
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Access Bio does not currently have a style classification.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Access Bio. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +35.86%.
As of the last closing price of KR₩25,700, shares in Access Bio were trading +14.12% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Access Bio.
We do not have data on Access Bio's directors
We do not have data on Access Bio's shareholders